HUM Humana Inc.

380.10USD+0.03%Mkt Cap: 45.64B USDP/E: 37.07

Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including he…

Insiders, last 90 daysNet sellers
Institutional holders20 on file

Key Statistics

Company
Market Cap45.64B USD
Enterprise Value33.97B USD
Revenue (TTM)154.19B USD
Gross Profit20.06B USD
Net Income (TTM)1.19B USD
Revenue/Share1282.65 USD
Last Price380.10 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees67.1K
CountryUS
SectorHealthcare
IndustryHealthcare Plans
ISIN—
Valuation
P/E (Trailing)37.07
P/E (Forward)20.60
PEG1.13
EV/EBITDA11.19
EV/Revenue0.22
P/S0.30
P/B2.42
EPS (TTM)10.25 USD
EPS (Forward)18.45 USD
52W Range
163.1172% of range462.87
52W High462.87 USD
52W Low163.11 USD
Profitability
Gross Margin13.01%
Oper. Margin1.82%
EBITDA Margin1.97%
Profit Margin0.92%
ROE6.73%
ROA2.43%
ROIC17.98%
ROCE—
Growth
Revenue Growth26.10%
Earnings Growth-17.90%
Cash Flow & Leverage
Operating CF921.00M USD
CapEx (TTM)546.00M USD
FCF Margin2.14%
FCF Yield7.21%
Net Debt-11.73B USD
Net Debt/EBITDA-3.86
Net Debt/FCF-3.56
Balance Sheet
Debt/Equity0.70
Current Ratio1.65
Quick Ratio1.26
Book Value/Sh156.74 USD
Cash/Share209.06 USD
Dividends
Fwd Div Rate3.54 USD
Trail. Div Rate3.54 USD
Div. Yield0.92%
5Y Avg Yield0.87%
Payout Ratio34.54%
Ex-Div DateDec 24, 2026
Pay DateJan 29, 2027
Splits
Last Split3:2
Split DateAug 1, 1991
Analyst Consensus
Rating1.9 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)508.54 USD
Upside (mean)+33.8%
Target Range280.00 USD – 602.00 USD
280.00+33.8% to mean602.00
# Analysts24
Ownership
Shares Out.120.10M
Float119.86M
Insiders0.22%
Institutions99.49%
Short Interest
Short Ratio1.8d
Short % Float2.63%
Short % Out.2.31%
Shares Short2.78M
Short (prev mo.)2.79M
Technical
SMA 50410.39 (-7.4%)
SMA 200320.92 (+18.4%)
Beta0.64
S&P 52W Chg12.00%
Avg Vol (30d)1.62M
Avg Vol (10d)2.18M
Technical Indicators
RSI (14)36.7
MACD1.4469
MACD Signal6.4951
MACD Hist.-5.0482
BB Upper463.68 USD
BB Middle423.03 USD
BB Lower382.38 USD
BB Width19.22%
ATR (14)20.39 USD
Vol Ratio (20d)1.22x

About Humana (NYSE: HUM)

›

Humana (NYSE: HUM) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Healthcare Plans industry, part of the Healthcare sector, and reports about 67,060 employees.

The shares were at 380.10 USD on 19 November 2026, up 61.9% over 52 weeks. Its 52-week range is 163.11 USD to 462.87 USD: the price is 17.9% below the high and 133.0% above the low.

At a market capitalisation of 45.64B USD, it trades at 37.1 times trailing earnings and 20.6 times forward earnings. The median trailing P/E of its 9 largest Healthcare Plans peers is 18.9, a premium of 97% for HUM. It pays a dividend yielding 0.92% (it pays out 35% of its earnings), against a median of 2.42% among the dividend payers in that peer group.

Humana reports return on equity of 6.7%, an operating margin of 1.8% and revenue up 26.1% year over year.

It holds more cash than debt, a net cash position of 11.73B USD. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. 24 analysts cover the stock, with an average rating of Buy; their mean price target of 508.54 USD is 33.8% above the current price. The next earnings report is expected on 10 February 2027.